Alopecia Treatment Market to Rise at 5.2% CAGR till 2027; Companies such as Johnson & Johnson, GlaxoSmithKline plc., and Merck & Co., Inc. to Focus on Varied Product Offerings: Fortune Business Insights™

 The global “alopecia treatment market” size is estimated to reach USD 13.45 Billion by 2027 on account of the increasing number of hair loss cases in people irrespective of gender and age. Alopecia areata is a medical condition that results in hair loss in patches for both males and females. The immune system of the body attacks the hair follicles and ultimately results in loss of hair on the scalp, eyebrows, eyelashes, and face.

According to a recent report by Fortune Business Insights titled, “Alopecia Treatment Market Size, Share & Industry Analysis, By Route of Administration (Topical, Injectable, Oral), By Gender Type (Male, Female), By Age Group (Below 18 years, 18 - 34 Years, 35 - 49 Years, Above 50 Years), By End User (Hospitals and Physician Offices, Dermatology Clinics, Others) and Regional Forecast, 2020-2027,” the market value stood at USD 8.89 Billion in 2019 and is anticipated to rise at a CAGR of 5.2% between 2020 to 2027.

Quick Buy Alopecia Treatment Market

Market Drivers

Massive Investments on Clinicals will Augment Growth

Various factors are responsible for the alopecia treatment of market growth. These include increasing adoption of a sedentary lifestyle, binge eating habits, cigarette consumption, and others that ultimately weaken the immune system. In addition to this, there is heavy investment in hair transplantation systems, and this will also add impetus to the market in the forecast period.

On the flip side, factors such as the side effects associated with this treatment procedure such as ejaculation disorders, impotency, enlargement or tenderness of breasts, and testicular pain may pose a major hindrance to the market in the coming years. Nevertheless, increasing investments in research and clinical trials are likely to create lucrative growth opportunities for the market in the coming years.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/alopecia-treatment-market-102822

List of Alopecia Treatment Market Manufacturers include:

  • Follicum AB
  • Concert Pharmaceuticals Inc.
  • Daiichi Sankyo
  • Johnson & Johnson
  • Merck & Co., Inc.,
  • Aclaris Therapeutics, Inc.
  • Fagron
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • GlaxoSmithKline plc.
  • Other Players

Related Reports

Continuous Renal Replacement Therapy Market Segments

Precision Diagnostics Market Competitive Landscape

Eye Supplements Market Demand

Histone Deacetylase Inhibitors Market Key Players

Food for Special Medical Purpose Market Business Opportunities

Urinary Incontinence Devices Market Analysis

Rheumatoid Arthritis Therapeutics Market Growth

Alopecia Treatment Market Trends

Pharmacovigilance Market Share

Sharps Containers Market Size

Pharmacovigilance Market Segments

Pharmacovigilance Market Competitive Landscape

Pharmacovigilance Market Demand

Pharmacovigilance Market Key Players

Pharmacovigilance Market Business Opportunities

Pharmacovigilance Market Analysis

Pharmacovigilance Market Growth

Pharmacovigilance Market Trends

Pharmacovigilance Market Share

Pharmacovigilance Market Size

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

LinkedIn | Twitter | Blogs

Comments

Post a Comment

Popular posts from this blog

Health Insurance Market to Exhibit 5.5% CAGR till 2028; Bharti AXA General Insurance’s Health AdvantEDGE to Provide Benefits amid COVID-19

  The global “ health insurance market ” size is set to reach USD 3,038.6 billion by 2028. Fortune Business Insights™ presented this information in a new study, titled, ““Health Insurance Market, 2021-2028.” The study further mentions that the market stood at USD 1,966.6 billion in 2020. It would exhibit a CAGR of   5.5%   in the forecast period between 2021-2028. Several government and private agencies are introducing new schemes to attract more customers. In December 2020, for instance, ICICI Lombard unveiled its latest ‘ICICI Lombard Complete Health Insurance’ featuring unique benefits and health plans.  Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/health-insurance-market-101985 COVID-19 Pandemic: Relaxations of Premiums May Hamper Growth The COVID-19 pandemic has compelled various companies to strengthen their existing schemes for meeting the high demand. They have started introducing new subscriptions including COVID-19 prote
Read more

Anti-obesity Drugs Market to Showcase 10.1% CAGR till 2027; Rising Concerns Regarding Obesity and Overweight Globally to Drive Growth, says Fortune Business Insights™

  The global “ anti-obesity drugs market ” size is set to grow significantly owing to the ever-increasing prevalence of obesity among the global population, observes Fortune Business Insights™ in its report, titled, “Anti-obesity Drugs Market Size, Share & COVID-19 Impact Analysis, By Type (Prescription Drugs and OTC Drugs), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The market size was USD 1,520.2 million in 2019 and is anticipated to reach USD 3,421.0 million by 2027, exhibiting a CAGR of 10.1% during the forecast period. Request a Sample Copy of the Research Report https://www.fortunebusinessinsights.com/anti-obesity-drugs-market-104783 Drivers & Restraints- Rising Cases of Obesity Worldwide to Drive Growth The increasing cases of obesity and overweight among patients globally due to inactive lifestyles and poor eating habits are anticipated to drive the anti-obesity drugs market growth. For instance,
Read more

Neurovascular Catheters Market to Grow at 7.1% CAGR till 2026; Development of Advanced Techniques for Brain Surgeries to Aid the Market: Fortune Business Insights™

  The global “ neurovascular catheters market size ” is projected to reach USD 1,083.5 million by 2026, exhibiting a CAGR of 7.1% during the forecast period. Increasing prevalence of stroke around the globe will be the prime growth driver for this market in the coming years, states Fortune Business Insights™ in its new report, titled “Neurovascular Catheters Market Size, Share & Industry Analysis, By Type (Microcatheters, Balloon Catheters, Thrombectomy Catheters, and Others), By Application (Hemorrhagic Stroke, and Ischemic Stroke), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026”. Data analysis by the World Stroke Organization revealed that every year there are more than 13.7 million new stroke cases worldwide, with nearly 25% of the people over the 25 years of age likely to suffer from stroke at least once in their lifetime. Furthermore, the Global Burden of Disease (GBD) study of 2018 found that strokes caused approximately 5.5 million deaths an
Read more